Researchers at the University of Washington have used machine learning to teach an AI system to identify when someone is having a cardiac arrest. The system learned to identify agonal breathing, which occurs when someone gasps for breath during cardiac arrest, with a high degree of accuracy. The technology can be embedded into a variety […]
Category: News
Study: EHRs may not capture the most accurate information about ophthalmic medications
When it comes to keeping track of prescribed medications between clinic visits, many patients rely on printed medication lists automatically generated from electronic health records.
Mimics Enlight Cardiovascular Planning Software Gets FDA Clearance
Materialise, a 3D printing company with a focus on patient-specific parts, has received FDA clearance for its Mimics Enlight cardiovascular planning software suite. The product’s initial application will be in planning complex transcatheter mitral valve replacement (TMVR) procedures. Developed with the help of the Henry Ford Health System in (Read more...)
eMacula Augmented Reality for Vision Impaired: Interview with Steve Willey, CEO of Innovega
Innovega Inc., a systems engineering and lens development company with offices in Washington and California, has created eMacula, a new generation of eyewear that combines smart contact lenses and stylish, lightweight glasses. The system will be tailored to the needs of vision impaired patients who will benefit from both lens-based vision correctio (Read more...)
Tumors Grown in 3D from Cancer Patient Samples for Drug Screening
Cancerous tumors can be very inconsistent in how they respond to different therapies. While the tumor of one patient can rapidly shrink when exposed to a given medication, another patient suffering from the same kind of tumor may not get any benefit from that same drug. This phenomenon highlights why personalized medicine is such an […]
Machine Learning Predicts Psychosis from Subtle Changes in Word Choices
Researchers from Emory University and Harvard University have developed a machine learning algorithm that can predict an individual’s likelihood for developing psychosis based on their speech patterns. Psychosis may be described as a “break with reality,” including hallucinations and delusions, which may arise from schizophrenia o (Read more...)
EnChroma Expands Leadership Team With Key Hires, Adds Over 100 New Retail Partners in the US, Europe and Canada
BERKELEY, Calif. & ST. LOUIS–(BUSINESS WIRE)–<a href="https://twitter.com/hashtag/colorishere?src=hash" target="_blank">#colorishere</a>–EnChroma Expands Leadership Team with Key Hires, Adds Over 100 New Retail Pa…
RIBOMIC annonce les premiers résultats positifs de l'essai clinique de phase 1/2a du RBM-007 (étude SUSHI) chez des patients atteints de dégénérescence maculaire liée à l'âge humide
TOKYO–(BUSINESS WIRE)–RIBOMIC, Inc., société pharmaceutique de stade clinique spécialisée dans les produits thérapeutiques à aptamères et cotée sur le Mothers Market de la Bourse de Tokyo (numéro de code : 4591), a annoncé aujourd’hui les premiers résultats positifs issus de l’étude SUSHI, étude clinique à dose ascendante unique de Phase 1/2a du RBM-007, aptamère anti-FGF2, chez neuf patients atteints de dégénérescence maculaire liée à l’âge humide (DMLA humide). L’étude SUSHI a atteint le cr
RIBOMIC gibt positive Topline-Ergebnisse der klinischen Phase-1/2a-Studie an RBM-007 (SUSHI-Studie) bei Patienten mit feuchter altersbedingter Makuladegeneration bekannt
TOKIO–(BUSINESS WIRE)–RIBOMIC, Inc., ein auf Aptamer-Therapeutika im klinischen Stadium spezialisiertes Pharmaunternehmen, das am Mothers-Markt der Tokioter Börse gehandelt wird (Börsenkürzel: 4591), gab heute positive Topline-Ergebnisse seiner SUSHI…
Study provides new insight into the heritability of coronary artery disease
A collaboration involving the Icahn School of Medicine at Mount Sinai, the German Heart Center Munich, AstraZeneca, and Karolinska Institutet in Sweden has demonstrated that more than 30 percent of heart disease risk stems from genetic factors, much mo…
Electric Brain Stimulation Shown to Improve Memory Function
Our memories often seem ephemeral, coming and going without any obvious reasons. Researchers at UCLA seem to have come up with a way to bring some memories back that would probably otherwise have gone missing forever. The team relied on transcranial direct current stimulation (tDCS), a technology that can direct low energy electricity into specific (Read more...)
Electric Brain Stimulation Shown to Improve Memory Function
Our memories often seem ephemeral, coming and going without any obvious reasons. Researchers at UCLA seem to have come up with a way to bring some memories back that would probably otherwise have gone missing forever. The team relied on transcranial direct current stimulation (tDCS), a technology that can direct low energy electricity into specific (Read more...)
Virtual Biopsy for Skin Lesions Using Vibrational Optical Coherence Tomography
Tissue biopsies of skin lesions can be unpleasant and quite painful. Moreover, a biopsy typically doesn’t sample the whole lesion and doesn’t provide much information about a given lesion’s size and depth. Now, scientists at Rutgers University have developed and tested a new device that relies on two different mechanisms to analyz (Read more...)
Global Sunglasses Market Projected to Reach $38.84 Billion by 2024 – Key Players Focus to Leverage Opportunities Posed by Emerging Markets to Expand Their Product Portfolio – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Sunglasses Market – Growth, Trends and Forecasts (2019 – 2024)” report has been added to ResearchAndMarkets.com’s offering. Global sunglasses market is forecasted to reach USD 38.84 billion by 2024 growing at a CAGR of 5.5% during the forecast period (2019-2024). Key Highlights The growth rate of sunglasses is driven by the increased consumer awareness and demand for protection against ultraviolet radiation and glare, as well as the growing popularity of sunglasses
Are Modest Gains From Two-Stent Glaucoma Surgery Worth Pursuing?
It may not replace trabeculectomy yet, but there is value associated with this second-generation microinvasive surgery. Medscape Ophthalmology
Ultra-Thin Probe Assesses Tissues Deep Within Lungs
Assessing the health of tissues deep inside the body is a major need and challenge in medicine. Imaging modalities such as MRI, CT, and ultrasound provide very little information about the composition and environment of tissues being examined. Now, researchers at the University of Edinburgh, Heriot-Watt University, and Bath University, all in the U (Read more...)
Molecular Motors Drill Through Cancer Cells
A couple of years ago a team of U.S. and U.K. scientists came up with a way of making molecular motors that can drill through cancer cells, destroying them in the process. The researchers, from Rice University, Durham University, and North Carolina State University, used an ultraviolet (UV) light source to energize these motors, but […]
How Medical Device Manufacturers Can Change Marketing and Sales Capabilities
Life science organizations successfully increase sales when all departments collaborate to enhance results. Sharing information between departments can focus on fulfilling the needs of customers and strengthening commercial performance. At the 9th Digital Marketing for Medical Devices, taking place on August 5–7 in Minneapolis, (Read more...)
New Microfluidic Chip to Accurately Model Blood-Brain Barrier
Researchers from the Wyss Institute at Harvard University have developed a new microfluidic lab-on-a-chip device that aims to more accurately model the complex biological properties of the blood-brain barrier (BBB). Their work, recently published in Nature Communications, demonstrates the device is able to mimic the highly selective drug and antibo (Read more...)
RIBOMIC Announces Positive Top-Line Results from the Phase 1/2a Clinical Trial of RBM-007 (SUSHI Study) in Subjects with Wet Age-Related Macular Degeneration
TOKYO–(BUSINESS WIRE)–RIBOMIC, Inc., a clinical stage pharmaceutical company specializing in aptamer therapeutics and traded on the Mothers Market of the Tokyo Stock Exchange (Code Number: 4591), today announced positive top-line results from its SUS…